1. Home
  2. AVAV vs SYRE Comparison

AVAV vs SYRE Comparison

Compare AVAV & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AeroVironment Inc.

AVAV

AeroVironment Inc.

N/A

Current Price

$166.90

Market Cap

8.6B

Sector

Industrials

ML Signal

N/A

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

N/A

Current Price

$104.34

Market Cap

8.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVAV
SYRE
Founded
1971
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
8.5B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
AVAV
SYRE
Price
$166.90
$104.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
12
Target Price
$316.88
$85.08
AVG Volume (30 Days)
1.4M
1.0M
Earning Date
03-10-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$135.55
N/A
Revenue Next Year
$14.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$135.20
$14.51
52 Week High
$417.86
$108.14

Technical Indicators

Market Signals
Indicator
AVAV
SYRE
Relative Strength Index (RSI) 57.37 58.74
Support Level $138.24 $92.37
Resistance Level $220.08 N/A
Average True Range (ATR) 8.83 5.52
MACD 3.10 -0.23
Stochastic Oscillator 77.54 74.41

Price Performance

Historical Comparison
AVAV
SYRE

About AVAV AeroVironment Inc.

AeroVironment Inc supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. Company operates in three segments: UxS, LMS, MW.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: